Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT01018160
Eligibility Criteria:
Inclusion Criteria:
* Patients complaining about heartburn or acid regurgitation, the typical GERD symptoms, more than once a week
* After a full explanation about the observational study, patients who fully understand it and sign a written consent form
Exclusion Criteria:
* Patients who took rabeprazole sodium within the last four weeks
* Patients who are hypersensitive to the active ingredient of rabeprazole sodium or benzimidazole
* Patient with other digestive tract diseases other than GERD (gastrointestinal cancer, liver disease, pancreatic disease, peptic ulcer, inflammatory digestive tract diseases \[in case of ulcer, however, scars from healed ulcer may be included\])
* Patients with other severe accompanying diseases including renal impairment, cerebrovascular disease, cardiovascular disease and severe respiratory disease
* Patients who must constantly take Proton Pump Inhibitors other than rabeprazole sodium during study period
* Pregnant or lactating women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01018160
Study Brief:
Protocol Section:
NCT01018160